With operations in the U.S., Asia, Europe and its domestic home market of Japan, Eisai employs more than 10,000 people worldwide. From its EMEA Knowledge Centre in Hatfield, UK, Eisai has recently expanded its business operations to include Europe, the Middle East, Africa, Russia and Oceania (EMEA). Eisai EMEA has sales and marketing operations in over 20 markets, including the United Kingdom, France, Germany, Italy, Spain, Switzerland, Sweden, Ireland, Austria, Denmark, Finland, Norway, Portugal, Czech Republic, Slovakia, the Netherlands, Belgium, Luxembourg, Russia and the Middle East.
For further information please visit our web site http://www.eisai.co.uk
References
1. SPC Halaven (updated August 2013). Available at: http://www.medicines.org.uk/emc/medicine.... Last accessed October 2013
2. Epidemiology of breast cancer in the Czech Republic. Mamo.cz. http://www.mamo.cz/index-en.php?pg=professionals--breast-can... Last accessed November 2013
3. Globocan 2008 statistics http://globocan.iarc.fr/factsheet.asp Last accessed October 2013
4. Cortes J, O'Shaughnessy J, Loesch D, et al. Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study. The Lancet. 2011; 377: 914 -923
5. World Health Organization. Atlas of Health in Europe. 2003. World Health Organization, Regional Office of Europe, Copenhagen, Denmark.
6. Cancer Research UK. Breast cancer incidence statistics. http://www.cancerresearchuk.org/cancer-info/cancerstats/type... [http://www.cancerresearchuk.org/cancer-info/cancerstats/type... ]. Last accessed November 2013.
Date of preparation: December 2013
Job code: Halaven-UK0227
CONTACT: Media Enquiries: Eisai Europe Ltd, Cressida Robson / CharlotteAndrews, +44(0)7908-314-155 / +44(0)7947-231-513 ,Cressida_Robson@eisai.net, Charlotte_Andrews@eisai.net. , Tonic LifeCommunications, Siobhan Reilly / April Kenneally, +44(0)207-798-9999 /+44(0)207-798-9263, siobhan.reilly@toniclc.com, april.kenneally@toniclc.com
